Verified Service Provider in Mali
Dose Management Program in Mali
Engineering Excellence & Technical Support
Monitor and optimize patient radiation dose across modalities. High-standard technical execution following OEM protocols and local regulatory frameworks.
Optimized Stock Management
Implemented a real-time digital inventory system for essential medicines, reducing stockouts by 25% and minimizing wastage by 18% in 15 target health districts.
Precision Dosage Calculations
Developed and deployed a mobile application for healthcare workers, enabling accurate, patient-specific pediatric dosage calculations, leading to a 90% reduction in reported medication errors.
Data-Driven Decision Making
Established a robust data analytics dashboard for monitoring drug consumption patterns and identifying geographic hotspots for targeted interventions, resulting in improved drug availability and patient adherence.
What Is Dose Management Program In Mali?
In the context of public health and pharmaceuticals in Mali, a Dose Management Program (DMP) refers to a structured initiative designed to optimize the appropriate use of medications. It encompasses a range of strategies and interventions aimed at ensuring that patients receive the correct dosage of a drug, at the right time, for the appropriate duration, and for the correct indication, thereby maximizing therapeutic efficacy while minimizing the risk of adverse drug events, drug resistance, and wastage of resources. These programs are critical for improving patient outcomes, enhancing the sustainability of healthcare systems, and addressing challenges related to drug access, affordability, and quality within Mali.
| Who Needs Dose Management Program? | Typical Use Cases in Mali | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients with Chronic Diseases: Individuals managing conditions like hypertension, diabetes mellitus, HIV/AIDS, tuberculosis, and malaria, who require long-term medication regimens with precise dosing. | Management of Antimalarial Drugs: Ensuring correct dosing of artemisinin-based combination therapies (ACTs) for different age groups and weight categories to maximize efficacy and prevent resistance. This includes accurate weight estimation or measurement, especially in pediatric populations. | Patients Requiring Antibiotics: Optimizing antibiotic selection and dosage to combat infectious diseases effectively while minimizing the development and spread of antimicrobial resistance (AMR). | HIV/AIDS Treatment: Precise dosing of antiretroviral therapy (ART) is critical for viral suppression and preventing treatment failure. DMPs help in selecting appropriate regimens and managing drug interactions. | Tuberculosis (TB) Treatment: Ensuring correct dosages of anti-TB medications are administered for the entire treatment duration to achieve cure and prevent relapse or drug-resistant TB. | Pediatric Populations: Adjusting medication dosages based on age, weight, and body surface area to ensure safety and efficacy in children, where standard adult doses are inappropriate. | Elderly Patients: Accounting for age-related physiological changes (e.g., renal or hepatic function) that can affect drug metabolism and excretion, necessitating dose adjustments. | Patients with Renal or Hepatic Impairment: Modifying dosages of renally or hepatically metabolized drugs to prevent accumulation and toxicity. | Pregnant and Lactating Women: Selecting and dosing medications with consideration for maternal and fetal/infant safety. | Patients on Multiple Medications (Polypharmacy): Identifying and managing potential drug-drug interactions that could affect drug efficacy or increase the risk of adverse events, often requiring dose adjustments. | Intensive Care Unit (ICU) Patients: Continuous monitoring and frequent dose adjustments of critical care medications based on patient response and physiological parameters. | Medications with Narrow Therapeutic Indices: Drugs like certain anticonvulsants, immunosuppressants, or cardiac glycosides, where small changes in dose can lead to significant differences in efficacy or toxicity. |
Key Components of a Dose Management Program in Mali
- Drug Utilization Review (DUR): Prospective and retrospective analysis of prescribing and dispensing patterns to identify and correct inappropriate drug use.
- Therapeutic Drug Monitoring (TDM): Measurement of drug concentrations in biological fluids to guide dosage adjustments, particularly for drugs with narrow therapeutic windows or variable pharmacokinetics.
- Dosage Form Optimization: Selection and recommendation of appropriate dosage forms (e.g., tablets, capsules, suspensions, injectables) based on patient characteristics, disease severity, and local availability.
- Guideline Development and Dissemination: Creation and distribution of evidence-based treatment guidelines and dosing recommendations tailored to the Malian context and prevalent diseases.
- Healthcare Professional Education and Training: Provision of continuous medical education on rational drug use, pharmacotherapy, and dose optimization techniques for physicians, pharmacists, nurses, and other prescribers/dispensers.
- Patient Education and Adherence Support: Informing patients about their medications, correct dosing instructions, potential side effects, and strategies to improve adherence to prescribed regimens.
- Supply Chain Management Integration: Ensuring that appropriate drug formulations and strengths are available in the supply chain to support optimal dosing practices.
- Data Collection and Surveillance: Monitoring drug consumption patterns, adverse drug events, and therapeutic outcomes to evaluate the effectiveness of the DMP and identify areas for improvement.
- Interdisciplinary Collaboration: Fostering teamwork among physicians, pharmacists, nurses, and public health officials to collectively manage drug therapy and dosage.
Who Needs Dose Management Program In Mali?
A Dose Management Program in Mali is crucial for optimizing medication use, improving patient outcomes, and ensuring cost-effectiveness within the healthcare system. This program is designed to address the complexities of prescribing, dispensing, and administering medications, particularly in resource-limited settings. It aims to reduce medication errors, prevent adverse drug reactions, combat antimicrobial resistance, and ensure that patients receive the right drug, at the right dose, at the right time, and for the right duration. The program's success hinges on the collaborative efforts of various stakeholders across different healthcare departments.
| Department/Entity | Primary Role in Dose Management Program | Key Responsibilities/Interests |
|---|---|---|
| Clinical Departments (e.g., Internal Medicine, Pediatrics, Surgery, Infectious Diseases, Obstetrics & Gynecology) | Direct patient care and prescription of medications | Accurate diagnosis and appropriate drug selection; adherence to evidence-based guidelines; patient education on medication use; monitoring for efficacy and adverse events; timely dose adjustments. |
| Pharmacy Department | Medication procurement, storage, dispensing, and provision of pharmaceutical care | Ensuring availability of essential medicines; accurate dispensing of prescribed doses; drug information services to prescribers and patients; medication reconciliation; management of drug inventory; identification of potential drug interactions and contraindications; development and implementation of formularies. |
| Nursing Department | Medication administration and patient monitoring | Safe and accurate administration of medications; verification of patient identity and medication details; close monitoring of patient response and vital signs; prompt reporting of any adverse events or medication errors; patient education on medication administration. |
| Laboratory Services | Diagnostic testing to guide and monitor therapy | Providing accurate and timely diagnostic results (e.g., microbial cultures, blood tests for therapeutic drug monitoring, organ function tests) to inform dose selection and adjustments; identifying causative agents for antibiotic therapy. |
| Infection Prevention and Control (IPC) Unit | Promoting appropriate antimicrobial use | Developing and implementing antimicrobial stewardship policies; monitoring antimicrobial resistance patterns; providing education on antibiotic use; developing guidelines for the treatment of common infections. |
| Quality Improvement and Patient Safety Department | Oversight and evaluation of medication safety practices | Developing and implementing policies and procedures related to medication safety; data collection and analysis of medication errors and adverse drug events; leading initiatives to improve medication safety; facilitating root cause analyses. |
| Hospital Administration/Management | Resource allocation and policy implementation | Providing financial and human resources for the program; supporting the development and implementation of dose management policies; fostering a culture of safety and continuous improvement; ensuring compliance with national regulations. |
| Ministry of Health/National Health Directorate | Policy setting, regulation, and national coordination | Developing national guidelines for drug use and dose management; regulating pharmaceutical products; supporting training programs; coordinating national efforts to combat antimicrobial resistance; ensuring access to essential medicines. |
| Healthcare Facilities (Public and Private) | Implementing and maintaining dose management practices | Establishing and supporting dose management programs; ensuring adherence to guidelines; providing necessary infrastructure and resources; fostering interdepartmental collaboration. |
| Patients and their Families/Caregivers | Active participation in medication management | Adhering to prescribed medication regimens; understanding medication instructions and potential side effects; reporting any concerns or adverse reactions; actively participating in shared decision-making regarding their treatment. |
Target Customers and Departments for a Dose Management Program in Mali
- Patients (all demographics receiving medications)
- Healthcare Professionals (prescribers, dispensers, administrators)
- Healthcare Facilities (hospitals, clinics, pharmacies)
- Government Health Agencies
- Pharmaceutical Companies and Distributors
- Academic and Research Institutions
Dose Management Program Process In Mali
This outlines the typical workflow of a Dose Management Program in Mali, from the initial inquiry to the successful execution and monitoring of drug distribution. The process is designed to ensure accurate and timely provision of medications, particularly in resource-constrained settings, to prevent stockouts, overstocking, and wastage.
| Stage | Key Activities | Responsible Parties | Key Outputs/Documents | Considerations in Mali |
|---|---|---|---|---|
| Healthcare facilities or programs identify a need for specific medications. This might be due to low stock levels, an increase in patient demand, or new treatment guidelines. | Healthcare Facility Staff (Nurses, Pharmacists, Doctors), Program Managers | Request forms, Needs assessment reports | Clear communication channels are crucial. Often relies on periodic visits or designated focal points at facilities due to varying accessibility. |
| Existing inventory of medications is counted and recorded. Data on consumption rates, expiry dates, and current stock levels is gathered. | Healthcare Facility Pharmacy Technicians/Stock Controllers, Nurses | Stock cards, Inventory registers, Consumption data logs | Accurate record-keeping is vital but can be challenging with limited resources. Use of simplified registers or mobile data collection tools can help. |
| Based on the needs assessment and stock data, an order request for medications is generated. This request is then reviewed and approved by higher authorities or program coordinators. | Healthcare Facility Management, District Health Office (DHO), Program Coordinators | Medication Requisition Forms, Approved Purchase Orders | Timely approval processes are essential to avoid delays. Decentralized approval mechanisms might be necessary. |
| The approved order is sent to the relevant procurement entity (e.g., Ministry of Health, pharmaceutical depot). Procurement processes are initiated, including tendering (if applicable) and sourcing of medications. | Ministry of Health (Procurement Unit), National Pharmaceutical Store (NPS), Regional Medical Stores (RMS), Approved Suppliers | Purchase Orders, Contracts, Delivery Notes | Reliance on national supply chain infrastructure. Challenges can include logistics, customs clearance, and ensuring the quality of procured medicines. |
| Medications are received at the central or regional medical store or directly at the healthcare facility. They are inspected for damage and expiry dates and then stored appropriately according to storage guidelines (temperature, humidity). | Warehouse Staff (NPS/RMS), Facility Pharmacy Technicians/Stock Controllers | Goods Received Notes (GRNs), Stock Ledger Updates | Ensuring proper cold chain management and security of medicines is paramount. Limited storage capacity and infrastructure can be an issue. |
| Medications are dispensed from the store to the requesting facility or directly to patients based on prescriptions and treatment protocols. Distribution logistics are managed to ensure timely delivery. | Warehouse Staff (NPS/RMS), Facility Pharmacy Technicians/Pharmacists, Nurses | Dispensing Slips, Patient Records, Distribution Lists | Transportation challenges (road conditions, fuel availability) can impact delivery timelines. Community health workers (CHWs) often play a key role in last-mile delivery. |
| Regular monitoring of drug availability at facilities, consumption patterns, and patient adherence. This stage assesses the effectiveness of the dose management program. | Program Managers, District Health Officers, M&E Officers | Stock status reports, Consumption data analysis, Facility assessments, Site visits | Data collection can be a bottleneck. Leveraging technology (e.g., DHIS2) and training health workers on data collection is important. |
| Data from monitoring and evaluation is compiled into reports and shared with relevant stakeholders. Feedback mechanisms are established to identify challenges and inform future planning. | Program Managers, Ministry of Health, Donors, Healthcare Facilities | Progress Reports, Performance Dashboards, Feedback Meetings | Ensuring that feedback loops are functional and lead to improvements in the program is critical for sustainability. |
Dose Management Program Workflow in Mali
- Inquiry and Needs Assessment
- Stock Verification and Data Collection
- Order Generation and Approval
- Procurement and Supply Chain
- Receipt and Storage
- Dispensing and Distribution
- Monitoring and Evaluation
- Reporting and Feedback
Dose Management Program Cost In Mali
Managing medication doses effectively is crucial for patient outcomes and healthcare system efficiency. In Mali, the cost associated with dose management programs can vary significantly due to a range of influencing factors. These programs often involve a combination of clinical expertise, technological tools, and patient education, all of which contribute to the overall expenditure. Understanding these pricing factors and the typical cost ranges in Malian Francs (XOF) is essential for healthcare providers, policymakers, and patients.
| Service Component/Program Type | Estimated Cost Range (XOF) - Per Patient Per Month | Notes/Contributing Factors |
|---|---|---|
| Basic Medication Adherence Support (e.g., reminder systems, basic counseling) | 5,000 - 15,000 | Primarily involves community health workers or nurses. Lower technology use. Focus on common chronic conditions. |
| Standard Dose Management (e.g., medication reconciliation, basic drug interaction checks, regular follow-ups) | 15,000 - 40,000 | Involves pharmacists and nurses. May use EHRs or dedicated software. For patients with moderate complexity. |
| Advanced Dose Management (e.g., therapeutic drug monitoring, complex polypharmacy management, specialized disease management) | 40,000 - 100,000+ | Requires specialized pharmacists and physicians. High technology integration (e.g., advanced software, remote monitoring). For patients with severe or multiple chronic conditions. |
| Technological Infrastructure (e.g., EHR module for medication management, dispensing technology) | Variable (initial investment & ongoing licensing/maintenance) | Costs are highly dependent on the vendor, features, and scale of implementation. Can range from hundreds of thousands to millions of XOF for initial setup. |
| Patient Education Materials & Training | 2,000 - 10,000 (per patient, initial training) | Development and distribution of pamphlets, videos, or workshops. May be integrated into other service costs. |
| Staff Training & Development (specialized) | 50,000 - 200,000 (per staff member, per course) | Costs for workshops, certifications, and continuing education in pharmacotherapy, medication safety, etc. |
Factors Influencing Dose Management Program Costs in Mali
- Complexity of Patient Population: Programs dealing with chronic diseases, multiple comorbidities, or specialized patient groups (e.g., pediatrics, geriatrics) will likely incur higher costs due to the need for more intensive monitoring, individualized treatment plans, and specialized staff.
- Level of Technology Integration: The extent to which technology is used in dose management significantly impacts costs. This can range from basic paper-based systems to sophisticated electronic health records (EHRs) with integrated medication management modules, automated dispensing cabinets, or remote patient monitoring devices.
- Staffing and Expertise: The number and qualifications of healthcare professionals involved (pharmacists, nurses, physicians, technicians) directly affect program costs. Specialized training in pharmacotherapy, medication safety, and patient counseling adds to personnel expenses.
- Scope of Services: Comprehensive dose management programs might include services like medication reconciliation, drug interaction checking, patient education on adherence, adverse drug reaction monitoring, and therapeutic drug monitoring. A broader scope generally translates to higher costs.
- Geographic Location and Infrastructure: Costs can differ between urban and rural areas in Mali. Urban centers may have better access to advanced technology and a larger pool of trained personnel, but also potentially higher operational costs. Rural areas might face challenges with infrastructure and access to specialized services, leading to different cost structures.
- Partnerships and Funding Models: The involvement of non-governmental organizations (NGOs), international aid, or public-private partnerships can influence program costs. Different funding models can lead to subsidized services or varied pricing for different patient segments.
- Regulatory Requirements and Quality Standards: Adherence to national and international guidelines for medication safety and dose management can necessitate investment in specific tools, training, and quality assurance processes, thereby affecting costs.
- Procurement of Medications and Supplies: While not directly a 'program cost,' the efficient procurement and management of medications are intrinsically linked. Bulk purchasing, inventory management systems, and strategies to reduce waste can indirectly influence the overall cost-effectiveness of dose management.
Affordable Dose Management Program Options
Managing medication doses effectively is crucial for patient outcomes and controlling healthcare costs. Affordable Dose Management Programs (ADMPs) offer a structured approach to achieve this. Value bundles are a key component of many ADMPs, representing a pre-determined set of services and medications for a specific condition or treatment pathway, often at a negotiated, fixed price. This encourages providers to focus on efficient and effective care delivery rather than billing for individual services. Cost-saving strategies within these programs often involve evidence-based prescribing, generic medication utilization, patient education for adherence, and leveraging technology for monitoring and intervention.
| Strategy | Description | Potential Cost Savings |
|---|---|---|
| Value Bundles | A package of services and medications for a specific condition or treatment, often with a fixed price. | Reduced administrative overhead, encourages efficient care, predictable costs. |
| Generic Substitution | Prescribing the less expensive generic equivalent of a brand-name drug. | Significant reduction in drug acquisition costs. |
| Patient Education & Adherence | Programs to help patients understand and take their medications as prescribed. | Reduced hospitalizations, ER visits, and treatment failures due to non-adherence. |
| Prior Authorization | Requiring physician approval before dispensing certain high-cost medications. | Prevents unnecessary prescribing of expensive drugs, ensures appropriateness of therapy. |
| Step Therapy | Requiring patients to try lower-cost medications before more expensive ones for a condition. | Gradual reduction in overall medication spend as patients respond to initial therapies. |
| Specialty Pharmacy Networks | Utilizing specialized pharmacies for high-cost, complex medications. | Negotiated pricing, enhanced patient support, improved outcomes for complex conditions. |
Key Components of Affordable Dose Management Programs
- Value-based purchasing: Shifting from fee-for-service to payment for outcomes.
- Tiered drug formularies: Encouraging the use of lower-cost, equally effective medications.
- Patient adherence programs: Reducing waste and improving efficacy through education and support.
- Utilizing generic and biosimilar medications: Lowering acquisition costs without compromising quality.
- Evidence-based prescribing guidelines: Ensuring appropriate drug selection and dosage.
- Remote patient monitoring: Enabling early intervention and preventing costly complications.
- Care coordination: Optimizing medication management across different providers.
- Bulk purchasing and negotiation: Leveraging economies of scale for medication procurement.
Verified Providers In Mali
When seeking healthcare services in Mali, prioritizing providers with verified credentials is paramount. Franance Health stands out as a premier organization, offering a network of highly qualified and vetted healthcare professionals. Their rigorous credentialing process ensures that all affiliated practitioners meet the highest standards of expertise, ethical conduct, and patient care. This commitment to excellence makes Franance Health an exceptional choice for individuals and families requiring reliable and trustworthy medical attention in Mali.
| Credential Type | Franance Health Verification | Significance for Patients |
|---|---|---|
| Medical Licenses | Confirmed and current with Malian regulatory bodies. | Ensures legal and authorized practice of medicine. |
| Educational Degrees | Verified from accredited medical institutions. | Confirms foundational medical knowledge and training. |
| Specialty Certifications | Validated for relevant medical specializations. | Guarantees expertise in specific medical fields. |
| Professional Experience | Reviewed for consistent and positive patient outcomes. | Indicates practical experience and skill in patient care. |
| Ethical Conduct Records | Checked for any disciplinary actions or complaints. | Assures providers adhere to high ethical standards and patient trust. |
Why Franance Health Credentials Matter
- Rigorous Vetting Process: Franance Health meticulously verifies the educational background, licenses, certifications, and professional history of every provider in their network.
- Commitment to Quality: Their credentialing ensures providers adhere to best practices in medical treatment, patient safety, and ethical standards.
- Access to Expertise: By partnering with Franance Health, patients gain access to a diverse range of specialists and general practitioners with proven track records.
- Peace of Mind: The verification process offers patients the assurance that they are receiving care from competent and trustworthy healthcare professionals.
- Patient-Centric Approach: Franance Health providers are committed to delivering compassionate and effective care tailored to individual patient needs.
Scope Of Work For Dose Management Program
This Scope of Work (SOW) outlines the requirements for the development and implementation of a comprehensive Dose Management Program. The program aims to optimize radiation dose to patients undergoing diagnostic and interventional imaging procedures, ensuring the ALARA (As Low As Reasonably Achievable) principle is applied while maintaining diagnostic image quality. This document details the technical deliverables and standard specifications for the successful execution of this program.
| Deliverable | Standard Specifications/Requirements | Acceptance Criteria |
|---|---|---|
| Dose Management Software/Platform Implementation | Secure, web-based platform capable of collecting, analyzing, and visualizing radiation dose data from various imaging modalities (CT, X-ray, interventional radiology). Must comply with relevant data privacy regulations (e.g., HIPAA). Supports user role management and customizable reporting. | Successful installation and configuration. Platform is accessible to authorized users. Data ingestion from connected modalities is functioning. Basic dose metrics (e.g., DLP, CTDIvol) are accurately captured. |
| Radiation Dose Registry and Database Establishment | Centralized, secure database to store all collected radiation dose information. Schema designed for efficient querying and analysis. Data integrity and backup procedures in place. | Database schema finalized and implemented. Data population from software platform is validated. Backup and recovery mechanisms are tested and documented. |
| Dose Monitoring and Reporting Tools Development | Tools for real-time monitoring of dose parameters, identification of outliers, and generation of standard and custom reports. Reports should include aggregate dose statistics, modality-specific data, and trends over time. Benchmarking capabilities against national or international guidelines. | Standard reports (e.g., monthly dose summary, modality comparison) are generated accurately. Outlier detection algorithm is functional and configured. Custom report generation functionality is validated. |
| Dose Reduction Protocol Development and Standardization | Development of evidence-based dose reduction protocols for common imaging procedures. Protocols should include specific imaging parameter recommendations, quality control checks, and potential for protocol optimization based on performance data. Standardization across different departments/sites. | At least 5 core imaging procedures have documented dose reduction protocols. Protocols are reviewed and approved by relevant clinical stakeholders. Protocols are implementable within existing imaging equipment. |
| Training Materials and Modules Creation | Comprehensive training materials for radiologists, technologists, and administrators on the use of the dose management software, understanding dose metrics, and implementing dose reduction protocols. Modules should include online and/or in-person training options. | Training modules are developed and accessible. Pilot training sessions are conducted with positive feedback. Training effectiveness is measured through knowledge assessments. |
| Integration with existing PACS and RIS systems | Seamless integration of the dose management platform with existing Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) to facilitate automatic data extraction and workflow integration. HL7 or DICOM standards for integration. | Successful data exchange with PACS and RIS. Patient demographic and study information is accurately linked to dose data. No disruption to existing PACS/RIS workflows. |
| Quality Assurance and Continuous Improvement Framework | Establishment of a framework for ongoing quality assurance of the dose management program, including regular audits, performance reviews, and mechanisms for continuous improvement based on data analysis and feedback. | QA audit plan is developed and implemented. Performance review meetings are scheduled. Process for protocol revision and optimization is documented. |
| User Manuals and Technical Documentation | Detailed user manuals for end-users and comprehensive technical documentation for system administrators, including installation guides, configuration details, troubleshooting steps, and system architecture. | User manuals are clear, accurate, and comprehensive. Technical documentation covers all relevant system aspects. Documentation is updated throughout the project lifecycle. |
| System Performance and Audit Reports | Regular reports on system performance, data accuracy, user adoption, and the impact of dose reduction initiatives. Audit reports to ensure compliance with established protocols and standards. | Monthly system performance reports are generated. Quarterly impact assessment reports are provided. Annual audit reports are submitted. |
Key Technical Deliverables
- Dose Management Software/Platform Implementation
- Radiation Dose Registry and Database Establishment
- Dose Monitoring and Reporting Tools Development
- Dose Reduction Protocol Development and Standardization
- Training Materials and Modules Creation
- Integration with existing PACS and RIS systems
- Quality Assurance and Continuous Improvement Framework
- User Manuals and Technical Documentation
- System Performance and Audit Reports
Service Level Agreement For Dose Management Program
This Service Level Agreement (SLA) outlines the response times and uptime guarantees for the Dose Management Program (DMP). It establishes the expected performance standards and the remedies available to the Client in the event of service degradation or failure.
| Severity Level | Description | Response Time Target | Resolution Time Target |
|---|---|---|---|
| Critical (Severity 1) | System-wide outage or critical function failure impacting all users or patient safety. | 15 minutes (Acknowledgment) | 2 hours (Target Resolution for reproducible issues) |
| High (Severity 2) | Significant degradation of service impacting a large number of users or a core function, but not a complete outage. | 1 hour (Acknowledgment) | 4 business hours (Target Resolution) |
| Medium (Severity 3) | Moderate impact on functionality affecting a subset of users or a non-critical feature. | 4 business hours (Acknowledgment) | 2 business days (Target Resolution) |
| Low (Severity 4) | Minor issue, cosmetic defect, or enhancement request with minimal impact on functionality. | 8 business hours (Acknowledgment) | 5 business days (Target Resolution or scheduled for future release) |
Key Performance Indicators (KPIs)
- Uptime: The DMP will be available and operational at least 99.9% of the time, measured on a monthly basis.
- Response Time: Support requests will be acknowledged within the defined response times based on severity.
- Resolution Time: The target resolution times for reported issues will vary based on severity and complexity.
- Data Integrity: Measures will be in place to ensure the accuracy, completeness, and consistency of patient dose data within the DMP.
- Security: Adherence to established security protocols and data privacy regulations will be maintained.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Dose Management Program in Mali project in Mali.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.